abstract |
ABSTRACT OF THE DISCLOSURE This invention relates to 9-thia- and oxothia- and 9-dioxothia-11,12-seco-prostaglandins and processes for their manufacture. These compounds have prostaglandin-like biological activity and are particularly useful for the treatment of skin diseases such as psoriasis, for the prevention of thrombus formation, and in stimulating the production of growth hormone in intact animals. |